AU Stock MarketDetailed Quotes

PER Percheron Therapeutics Ltd

Watchlist
  • 0.011
  • -0.002-15.38%
20min DelayMarket Closed Feb 28 16:00 AET
11.96MMarket Cap-0.79P/E (Static)

Percheron Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Percheron Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H11.200M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/H11.200M / 0.000--

Percheron Therapeutics Ltd Earnings Reports

  • Percheron Therapeutics Ltd: Letter From The Chair and Half Year Accounts

    Feb 18 19:30 ET

  • Percheron Therapeutics Ltd: Percheron Receives $2.35 million R&D Tax Incentive Rebate

    Oct 7, 2024 18:37 ET

  • Percheron Therapeutics Ltd: Appendix 4E and Annual Report

    Aug 29, 2024 01:11 ET

  • Percheron Therapeutics Ltd: Half Yearly Report and Accounts

    Feb 28, 2024 01:20 ET

    • Read more

    Trending Stocks
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    Telstra Group Ltd
    TLS
    4.23% 0.18
    Westpac Banking Corp
    WBC
    4.62% 1.47
    CommBank
    CBA
    2.97% 4.65
    ANZ Group Holdings Ltd
    ANZ
    5.94% 1.77
    National Australia Bank Ltd
    NAB
    4.76% 1.68

    Unlock the Full List